ENDRA Life Sciences Inc.
NDRA
Price:
$5.09
Market Cap:
$2.73M
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, ...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2017-06-30
Stock Exchange
NASDAQ
Ticker
NDRA
PE Ratio
[-0.03]
ROE
[-141.35%]
Current Ratio
[6.10]
Dividend Yield
[0%]
Enterprise Value
[-814784.00]
Dividend History
The ROE as of November 2024 (TTM) for ENDRA Life Sciences Inc. (NDRA) is -141.35%
According to ENDRA Life Sciences Inc.’s latest financial reports and current stock price. The company's current ROE is -141.35%. This represents a change of 250.57% compared to the average of -40.32% of the last 4 quarters.
ENDRA Life Sciences Inc. (NDRA) Historical ROE (quarterly & annually)
How has NDRA ROE performed in the past?
The mean historical ROE of ENDRA Life Sciences Inc. over the last ten years is -217.75%. The current -141.35% ROE has changed -35.09% with respect to the historical average. Over the past ten years (40 quarters), NDRA's ROE was at its highest in in the September 2018 quarter at 602.82%. The ROE was at its lowest in in the March 2022 quarter at -31517451.45%.
Average
-217.75%
Median
-172.35%
Minimum
-910.59%
Maximum
310.52%
ENDRA Life Sciences Inc. (NDRA) ROE by Quarter and Year
Discovering the peaks and valleys of ENDRA Life Sciences Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 152.75%
Maximum Annual ROE = 310.52%
Minimum Annual Increase = -134.10%
Minimum Annual ROE = -910.59%
| Year | ROE | Change |
|---|---|---|
| 2023 | -177.77% | -2.98% |
| 2022 | -183.23% | 76.59% |
| 2021 | -103.76% | -37.84% |
| 2020 | -166.92% | -48.91% |
| 2019 | -326.73% | 108.39% |
| 2018 | -156.79% | 53.83% |
| 2017 | -101.92% | -132.82% |
| 2016 | 310.52% | -134.10% |
| 2015 | -910.59% | 152.75% |
ENDRA Life Sciences Inc. (NDRA) Average ROE
How has NDRA ROE performed in the past?
The current ROE of ENDRA Life Sciences Inc. (NDRA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-154.92%
5-year avg
-191.68%
10-year avg
-217.75%
ENDRA Life Sciences Inc. (NDRA) ROE vs. Peers
How is NDRA’s ROE compared to its peers?
ENDRA Life Sciences Inc.’s ROE is less than Burning Rock Biotech Limited (0%), greater than Neuronetics, Inc. (-74.92%), greater than DarioHealth Corp. (-160.79%), greater than Genetron Holdings Limited (-11.69%), less than Sera Prognostics, Inc. (0%), greater than Star Equity Holdings, Inc. (-51.73%), greater than Standard BioTools Inc. (-16.64%), greater than Biodesix, Inc. (-28.64%), greater than HTG Molecular Diagnostics, Inc. (-277.36%), greater than Intelligent Bio Solutions Inc. (-273.49%), greater than bioAffinity Technologies, Inc. (-144.39%), greater than SeqLL Inc. (-202.71%), less than Interpace Biosciences, Inc. (-0.04%), greater than null (-35.22%),
| Company | ROE | Market cap |
|---|---|---|
| 0% | $54.55M | |
| -74.92% | $26.86M | |
| -160.79% | $28.80M | |
| -11.69% | $127.29M | |
| 0% | $214.54M | |
| -51.73% | $9.49M | |
| -16.64% | $595.61M | |
| -28.64% | $186.20M | |
| -277.36% | $1.06M | |
| -273.49% | $6.80M | |
| -144.39% | $8.77M | |
| -202.71% | $0 | |
| -0.04% | $11.72M | |
| -35.22% | $0 |
Build a custom stock screener for ENDRA Life Sciences Inc. (NDRA) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ENDRA Life Sciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
ENDRA Life Sciences Inc. (NDRA) and other stocks custom spreadsheet templates
The easiest way to analyze a company like ENDRA Life Sciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is ENDRA Life Sciences Inc.'s ROE?
How is the ROE calculated for ENDRA Life Sciences Inc. (NDRA)?
What is the highest ROE for ENDRA Life Sciences Inc. (NDRA)?
What is the 3-year average ROE for ENDRA Life Sciences Inc. (NDRA)?
What is the 5-year average ROE for ENDRA Life Sciences Inc. (NDRA)?
How does the current ROE for ENDRA Life Sciences Inc. (NDRA) compare to its historical average?